Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Technology Advances: Next-Generation Diagnostics Offer On-the-Spot Results
Dorothy J. Schirf, MD, MDLinx Oncology
Off-Label Use: Sitting In Limbo
Roberta Buell, MBA, Sausalito Healthcare Partners
Clinical Trial Watch: Trial Finds Virtual Colonoscopy Comparable to Standard Colonoscopy
Tracy Hampton, PhD, MDLinx Oncology
  See all
colon cancer; apoptosis Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Signaling and regulatory mechanisms of integrin ανβ6 on the apoptosis of colon cancer cells
Cancer Letters, 07/03/08
Print     Email This Article     Save in My Library   Free Abstract
Zhao-yang Z et al. - In a study to investigate apoptosis and its related signal pathways to integrin αvβ6 in colon cancer cells, it was shown that integrin αvβ6 played an important role in inhibiting apoptosis in colon cancer cells, and the signaling involved the mitochondrial pathway

Methods
  • The function of integrin αvβ6 was blocked in HT29 cells used the monoclonal antibody

Results
  • After blocking the function of integrin αvβ6 in HT29 cells used the monoclonal antibody, apoptotic cells increased markedly
  • Cytochrome C released from mitochondria into cytosol, Bcl-2 decreased while Bax increased significantly, and Fas and Fas-ligand had no change
  • Activities of caspase-3 and caspase-9 increased, while caspase-8 remained unchanged
  • Expression of phosphorylated extracellular signal-related kinase decreased

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.